ClearCut Medical

first application PIC new
3 arrows-12

20-30% patients avoide 2nd surgery

First Application

Breast Cancer Surgery

In our initial targeted markets of North America, Europe, Australia/New Zealand and Japan, 20-30% of breast cancer lumpectomy surgery patients undergo avoidable 2nd surgeries. We exist to help correct that through the novel use of the gold standard in hospital imaging, intraoperative MRI.

A new frontier in cancer surgery

Untapped global opportunity

Platform applications in cancer surgery.

Markets to Serve

Interested in learning more?

Remove your doubts on the spot